Skip to Content

GX EJ7 (Epivir 300 mg)

Generic Name: lamivudine

Pill with imprint GX EJ7 is Gray, Four-sided and has been identified as Epivir 300 mg. It is supplied by GlaxoSmithKline.

Epivir is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Epivir 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for GX EJ7

Epivir 300 mg GX EJ7
Epivir 300 mg GX EJ7
Epivir 300 mg GX EJ7
Epivir 300 mg GX EJ7  Front
Epivir 300 mg GX EJ7  Back

Epivir

Generic Name:
lamivudine
Imprint:
GX EJ7
Strength:
300 mg
Color:
Gray
Size:
17.00 mm
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
GlaxoSmithKline
Inactive Ingredients:
ferric oxide black
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide